Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
View Patent ↗In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.
1. A method of reducing risk of cardiovascular death in a subject with established cardiovascular disease, the method comprising administering to said subject about 4 g of ethyl icosapentate per day for a period effective to reduce risk of cardiovascular death in the subject.
2. The method of claim 1 , wherein the subject has a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL and a fasting baseline LDL-C level of about 40 mg/dL to about 100 mg/dL.
3. The method of claim 1 , wherein the ethyl icosapentate is present in a pharmaceutical composition and the ethyl icosapentate comprises at least about 96 wt. % of all omega-3 fatty acids in the pharmaceutical composition.
4. The method of claim 3 , wherein about 1 g of the pharmaceutical composition is present in each of 4 capsules.
5. The method of claim 1 , wherein said period ends at least 2 years after initial administration of the ethyl icosapentate to the subject.
6. The method of claim 1 , wherein the subject is on statin therapy.
7. The method of claim 1 , wherein the subject has a triglyceride level of at least 135 mg/dL and is on statin therapy.